 |
|
|
| |
Characterizing Resistance-Associated Mutations and Virological Status Among People Living With HIV Receiving Regimens Containing Bictegravir, Cabotegravir, or Dolutegravir
|
| |
| |
Glasgow 2026 Nov 8-11
Sara N Levintow1, Paul McDwyer2, Ziwei Yin2, Wenyi Wang2, Michelle L D'Antoni2, Travis Lim2
1IQVIA, Durham, NC, USA; 2Gilead Sciences, Inc., Foster City, CA, USA
Download the PDF here
|
| |
|
|
|
|
|
